Muscle Protein SynthesisBlendNCT05386771
Effects of Whey and Collagen Protein Blend on Protein Synthesis Rates
A study testing Whey/collagen protein blend and Resistance exercise in people with Muscle Protein Synthesis, run by Maastricht University Medical Center at 1 site in Netherlands.
Trial summary
Rationale: Protein ingestion stimulates muscle protein synthesis and augments the muscle protein synthetic response to a single exercise session. In support, protein supplementation has been shown to augment the gains in muscle mass and strength following resistance exercise training. Read more about this study
- Who is it for?
- Ages 18 to 35 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Muscle Protein Synthesis
- What is being tested?
- Whey/collagen protein blend and Resistance exercise
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 36 participants
- Where
- 1 siteNetherlands
- Study dates
- 6 Sep 2022to 3 Apr 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Males
- Aged between 18-35 years
- Healthy, recreationally active (performing exercise 3 times per week or less in the past 6 months)
- BMI 18.5 - 30 kg/m2
- No physical limitations (i.e. able to perform all activities associated with daily living in an independent manner).
Who cannot join
- Females
- Musculoskeletal disorders
- Use of any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescribed acne medications).
- Participation in any structured regular exercise program
- Chronic use of gastric acid suppressing medication or anti-coagulants
- Pathologies of the gastrointestinal tract
- Blood donation in the past 2 months
Trial locations and contacts
1 site in 1 country.
Netherlands1 site
Maastricht University Medical Centre+
Maastricht, Limburg, 6229ER
About this study
Official title: The Effect of Ingesting a Whey and Collagen Protein Blend on Myofibrillar and Connective Tissue Protein Synthesis Rates at Rest and During Recovery From Exercise
Rationale: Protein ingestion stimulates muscle protein synthesis and augments the muscle protein synthetic response to a single exercise session. In support, protein supplementation has been shown to augment the gains in muscle mass and strength following resistance exercise training. The force generated by contracting muscle is transferred through a network of connective tissue proteins towards the bone. Consequently, remodeling of skeletal muscle connective tissue represents an essential component of skeletal muscle adaptation to exercise. The anabolic effect of a protein supplement is mainly determined by the plasma amino acid response after ingestion. Although whey protein is considered the preferred protein source to maximize myofibrillar protein synthesis rates, it contains insufficient glycine and proline to support the post-exercise increase in connective tissue protein synthesis rates. In contrast, collagen protein is rich in glycine and proline and has, therefore, been proposed as a preferred protein source to support connective tissue remodeling. Hence, the combined ingestion of whey plus collagen protein may therefore be preferred to stimulate both myofibrillar and collagen protein synthesis rates in skeletal muscle tissue. The most ideal protein supplement for stimulating both myofibrillar and collagen protein synthesis is one that gives a rapid initial rise in plasma amino acid concentrations including leucine, proline and glycine concentrations. However, the effect a blend of whey and collagen protein on myofibrillar and connective tissue protein synthesis rates is unknown.
Objective: To assess the effect of a whey and collagen protein blend versus a placebo on myofibrillar and connective tissue protein synthesis rates in muscle obtained during recovery from exercise and rest in vivo in humans.
Read more
Study design: Double-blind, parallel-group, placebo-controlled intervention study.
Study population: 28 healthy recreationally active males (18-35 y; BMI: 18.5-30 kg/m2).
Intervention: Participants will perform unilateral resistance exercise followed by the ingestion of either a blend of 25 g whey and 5 g collagen protein or a non-caloric placebo (flavored water). Continuous intravenous stable isotope amino acid tracer infusions will be applied, and plasma and muscle samples will be collected in order to assess protein synthesis rates in muscle tissue.
Read the detailed description
This study utilizes a double-blind, parallel-group, placebo-controlled intervention with two groups. In total, up to 38 healthy recreationally active male subjects (age: 18-35 y) will be included in the study, while 28 subjects need to finish the experimental test day. Subjects will perform a single unilateral resistance exercise session (leg press and leg extension) and will be randomly assigned to consume a beverage containing either a blend of 25 g whey and 5 g collagen protein or a placebo with non-nitrogenous, non-caloric flavored water. Blood and muscle biopsies will be collected while a primed continuous infusion of L-[ring-13C6] phenylalanine infusion will be administered. The duration of the entire study will be approximately 24 months. This period includes screening, testing and data analysis of all 28 subjects. Subject testing will be done after approximately 12 months.
Subjects will participate in one screening session. During this session, the study procedures will be explained again verbally and any remaining questions by the subject will be answered. Thereafter, the informed consent form will be signed. Subjects will be asked to fill in a medical questionnaire to gather information about their general health, medical history, use of medication and sports activities. Body height , body weight and body composition will be measured. The BIA is a simple and non-invasive procedure. Finally, subjects will be familiarized and tested for strength on the exercise machines (leg-press and leg-extension). Subjects will be instructed on proper single legged weight-lifting technique on each exercise machine (leg-press and leg-extension) and complete a standardized testing protocol to determine a measurement of maximal strength (1RM) on each exercise machine. The testing protocol requires that the subjects complete sets on each exercise machine increasing in weight until volitional fatigue occurs. The heaviest weight that could have been lifted with good execution of the exercise will be taken as the 1RM. Following the determination of 1RM, subjects will be scheduled for their experimental testing day.
All subjects will consume a standardized dinner the evening before each test day. The subjects will receive the meal after the screening test in a thermal bag. The subjects will be instructed to store the meal in a freezer until preparation and to prepare the meal themselves according to the instructions on the label. All subjects will be instructed to refrain from any sort of heavy physical exercise and alcohol intake 2 days before the test day. In addition, subjects will be asked to record their food intake and physical activity for 48 h before the start of the test day in a diary that will be provided during the screening.
Each subject will participate only in 1 experimental test day, which lasts ~9 h. The protocol is designed to assess the post-exercise plasma amino acid responses, myofibrillar and connective tissue protein synthesis.
A general overview of the study protocol is shown in Figure 1. At 7:45 am, following an overnight fast, subjects will arrive at the laboratory by car or public transportation. Subjects will rest in a supine position and a Teflon catheter will be inserted in a heated dorsal hand vein and placed in a hot-box (60°C) for arterialized blood sampling. In the contralateral arm, another Teflon catheter will be inserted for stable isotope infusion. A basal arterialized venous blood sample will be collected (t = -210 min), after which a single intravenous dose of L-[ring-13C6] phenylalanine (Cambridge Isotopes, Andover, MA) will be administered. Thereafter, a continuous infusion of L-[ring-13C6] phenylalanine will be started (t = -210 min) using a calibrated space plus infusomat pump (Braun, Melsungen, Germany), running for 510 min. A muscle biopsy from the upper leg that will not perform the unilateral exercise session will be collected at t = -180 min as a reference to assess post-absorptive muscle protein synthesis rates. After the first muscle biopsy was performed, muscle thickness of the rectus femoris muscle will be measured via ultrasound. Arterialized venous blood samples will be collected at t = -210, -180, -120, -60 and 0 min. At t = -45 min, a unilateral exercise, that consists of 4 sets of 8 repetitions on the leg press and leg extension machine at 80% 1RM 8 reps and last set until failure, will be performed. At t = 0 min muscle biopsies will be collected from the vastus lateralis muscle of both the rested and exercised leg. Immediately following blood collection (t = 0 min), subjects will ingest a test drink containing a blend of 25 g whey and 5 g collagen protein (PRO) or a non-caloric placebo (CON). Following ingestion of the test drink, arterialized venous blood samples will be collected at t = 30, 60, 90, 120, 180, 240 and 300 min. Furthermore, an additional muscle sample will be collected from the rested and exercised leg at t = 300 min.
- Conditions
- Muscle Protein Synthesis
- Being tested
- Whey/collagen protein blend, Resistance exercise
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Whey/collagen protein blendDietary supplement
Ingestion of 30g of protein dissolved in 300ml water consumed after an exercise session
Resistance exerciseBehavioural
A single resistance exercise session of the leg press and leg extension exercise
| Study group | Role | What they receive |
|---|---|---|
| Whey and collagen protein blend | Experimental | A blend of 25g of whey protein and 5g of collagen protein Receives: Dietary Supplement: Whey/collagen protein blend; Behavioral: Resistance exercise |
| Placebo | Placebo comparator | Water, same volume as the experimental study beverage Receives: Dietary Supplement: Whey/collagen protein blend; Behavioral: Resistance exercise |
What is being measured
The primary outcome is the main question the study is designed to answer.
Muscle protein synthesis rates exercised leg
Muscle protein synthesis rates are calculated using L-ring-13C6-phenylalanine tracer and provided as 1 integrated value over the specified timeframe using plasma as precursor of the exercised leg.
Measured: 0-5 hours
Muscle protein synthesis rates rested leg
Muscle protein synthesis rates are calculated using L-ring-13C6-phenylalanine tracer and provided as 1 integrated value over the specified timeframe using plasma as precursor of the rested leg.
Measured: 0-5 hours
Secondary outcomes (4)
Muscle protein synthesis rates
Muscle protein synthesis rates are calculated using L-ring-13C6-phenylalanine tracer and provided as 1 integrated value over the specified timeframe using plasma as precursor.
Measured: -3-0 hours
Plasma glucose concentrations
Plasma glucose concentrations
Measured: 0-5 hours
Plasma insulin concentrations
Plasma insulin concentrations
Measured: 0-5 hours
Plasma amino acids concentrations
Plasma amino acids concentrations
Measured: 0-5 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 May 2022
- Study start6 Sep 2022
- Primary completion3 Apr 2023
- Study completion3 Apr 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Muscle Protein SynthesisStudies of the same condition, open and under way.
- More trials run by Maastricht University Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Double-blind, parallel-group, placebo-controlled intervention study
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 36 participants (actual)
Sponsor and investigators
- Lead sponsor
- Maastricht University Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05386771
- Sponsor's protocol ID
- METC 22-017
- Acronym
- Blend
- Status last verified
- Sep 2022
- First submitted
- 18 May 2022
- Last updated
- 19 Jul 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Aussieker T, Kaiser J, Hermans WJH, Hendriks FK, Holwerda AM, Senden JM, VAN Kranenburg JMX, Goessens JPB, Braun U, Baar K, Snijders T, VAN Loon LJC. Ingestion of a Whey Plus Collagen Protein Blend Increases Myofibrillar and Muscle Connective Protein Synthesis Rates. Med Sci Sports Exerc. 2025 Mar 1;57(3):544-554. doi: 10.1249/MSS.0000000000003596. Epub 2024 Nov 6.
PubMed 39501478
Study at a glance
From the registry record, last updated by the sponsor on 19 Jul 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Ingesting a Whey and Collagen Protein Blend on Myofibrillar and Connective Tissue Protein Synthesis Rates at Rest and During Recovery From Exercise
- ClinicalTrials.gov ID
- NCT05386771
- Acronym / sponsor ID
- Blend / METC 22-017
- Conditions
- Muscle Protein Synthesis
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 36 participants (actual)
- Lead sponsor
- Maastricht University Medical CenterUniversity, hospital or other
- Study start
- 6 Sep 2022 (actual)
- Primary completion
- 3 Apr 2023 (actual)
- Study completion
- 3 Apr 2023 (actual)
- First posted
- 23 May 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Rationale: Protein ingestion stimulates muscle protein synthesis and augments the muscle protein synthetic response to a single exercise session. In support, protein supplementation has been shown to augment the gains in muscle mass and strength following resistance exercise training. The force generated by contracting muscle is transferred through a network of connective tissue proteins towards the bone. Consequently, remodeling of skeletal muscle connective tissue represents an essential component of skeletal muscle adaptation to exercise. The anabolic effect of a protein supplement is mainly determined by the plasma amino acid response after ingestion. Although whey protein is considered the preferred protein source to maximize myofibrillar protein synthesis rates, it contains insufficient glycine and proline to support the post-exercise increase in connective tissue protein synthesis rates. In contrast, collagen protein is rich in glycine and proline and has, therefore, been proposed as a preferred protein source to support connective tissue remodeling. Hence, the combined ingestion of whey plus collagen protein may therefore be preferred to stimulate both myofibrillar and collagen protein synthesis rates in skeletal muscle tissue. The most ideal protein supplement for stimulating both myofibrillar and collagen protein synthesis is one that gives a rapid initial rise in plasma amino acid concentrations including leucine, proline and glycine concentrations. However, the effect a blend of whey and collagen protein on myofibrillar and connective tissue protein synthesis rates is unknown.
Objective: To assess the effect of a whey and collagen protein blend versus a placebo on myofibrillar and connective tissue protein synthesis rates in muscle obtained during recovery from exercise and rest in vivo in humans.
Study design: Double-blind, parallel-group, placebo-controlled intervention study.
Study population: 28 healthy recreationally active males (18-35 y; BMI: 18.5-30 kg/m2).
Intervention: Participants will perform unilateral resistance exercise followed by the ingestion of either a blend of 25 g whey and 5 g collagen protein or a non-caloric placebo (flavored water). Continuous intravenous stable isotope amino acid tracer infusions will be applied, and plasma and muscle samples will be collected in order to assess protein synthesis rates in muscle tissue.
Detailed description
This study utilizes a double-blind, parallel-group, placebo-controlled intervention with two groups. In total, up to 38 healthy recreationally active male subjects (age: 18-35 y) will be included in the study, while 28 subjects need to finish the experimental test day. Subjects will perform a single unilateral resistance exercise session (leg press and leg extension) and will be randomly assigned to consume a beverage containing either a blend of 25 g whey and 5 g collagen protein or a placebo with non-nitrogenous, non-caloric flavored water. Blood and muscle biopsies will be collected while a primed continuous infusion of L-[ring-13C6] phenylalanine infusion will be administered. The duration of the entire study will be approximately 24 months. This period includes screening, testing and data analysis of all 28 subjects. Subject testing will be done after approximately 12 months.
Subjects will participate in one screening session. During this session, the study procedures will be explained again verbally and any remaining questions by the subject will be answered. Thereafter, the informed consent form will be signed. Subjects will be asked to fill in a medical questionnaire to gather information about their general health, medical history, use of medication and sports activities. Body height , body weight and body composition will be measured. The BIA is a simple and non-invasive procedure. Finally, subjects will be familiarized and tested for strength on the exercise machines (leg-press and leg-extension). Subjects will be instructed on proper single legged weight-lifting technique on each exercise machine (leg-press and leg-extension) and complete a standardized testing protocol to determine a measurement of maximal strength (1RM) on each exercise machine. The testing protocol requires that the subjects complete sets on each exercise machine increasing in weight until volitional fatigue occurs. The heaviest weight that could have been lifted with good execution of the exercise will be taken as the 1RM. Following the determination of 1RM, subjects will be scheduled for their experimental testing day.
All subjects will consume a standardized dinner the evening before each test day. The subjects will receive the meal after the screening test in a thermal bag. The subjects will be instructed to store the meal in a freezer until preparation and to prepare the meal themselves according to the instructions on the label. All subjects will be instructed to refrain from any sort of heavy physical exercise and alcohol intake 2 days before the test day. In addition, subjects will be asked to record their food intake and physical activity for 48 h before the start of the test day in a diary that will be provided during the screening.
Each subject will participate only in 1 experimental test day, which lasts ~9 h. The protocol is designed to assess the post-exercise plasma amino acid responses, myofibrillar and connective tissue protein synthesis.
A general overview of the study protocol is shown in Figure 1. At 7:45 am, following an overnight fast, subjects will arrive at the laboratory by car or public transportation. Subjects will rest in a supine position and a Teflon catheter will be inserted in a heated dorsal hand vein and placed in a hot-box (60°C) for arterialized blood sampling. In the contralateral arm, another Teflon catheter will be inserted for stable isotope infusion. A basal arterialized venous blood sample will be collected (t = -210 min), after which a single intravenous dose of L-[ring-13C6] phenylalanine (Cambridge Isotopes, Andover, MA) will be administered. Thereafter, a continuous infusion of L-[ring-13C6] phenylalanine will be started (t = -210 min) using a calibrated space plus infusomat pump (Braun, Melsungen, Germany), running for 510 min. A muscle biopsy from the upper leg that will not perform the unilateral exercise session will be collected at t = -180 min as a reference to assess post-absorptive muscle protein synthesis rates. After the first muscle biopsy was performed, muscle thickness of the rectus femoris muscle will be measured via ultrasound. Arterialized venous blood samples will be collected at t = -210, -180, -120, -60 and 0 min. At t = -45 min, a unilateral exercise, that consists of 4 sets of 8 repetitions on the leg press and leg extension machine at 80% 1RM 8 reps and last set until failure, will be performed. At t = 0 min muscle biopsies will be collected from the vastus lateralis muscle of both the rested and exercised leg. Immediately following blood collection (t = 0 min), subjects will ingest a test drink containing a blend of 25 g whey and 5 g collagen protein (PRO) or a non-caloric placebo (CON). Following ingestion of the test drink, arterialized venous blood samples will be collected at t = 30, 60, 90, 120, 180, 240 and 300 min. Furthermore, an additional muscle sample will be collected from the rested and exercised leg at t = 300 min.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- Double-blind, parallel-group, placebo-controlled intervention study
| Arm | Type | Receives |
|---|---|---|
| Whey and collagen protein blend | Experimental | Dietary Supplement: Whey/collagen protein blend, Behavioral: Resistance exerciseA blend of 25g of whey protein and 5g of collagen protein |
| Placebo | Placebo comparator | Dietary Supplement: Whey/collagen protein blend, Behavioral: Resistance exerciseWater, same volume as the experimental study beverage |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Males
- Aged between 18-35 years
- Healthy, recreationally active (performing exercise 3 times per week or less in the past 6 months)
- BMI 18.5 - 30 kg/m2
- No physical limitations (i.e. able to perform all activities associated with daily living in an independent manner).
Key exclusion criteria (7 listed)
- Females
- Musculoskeletal disorders
- Use of any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescribed acne medications).
- Participation in any structured regular exercise program
- Chronic use of gastric acid suppressing medication or anti-coagulants
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Whey/collagen protein blendIngestion of 30g of protein dissolved in 300ml water consumed after an exercise session | Dietary supplement | Placebo, Whey and collagen protein blend |
| Resistance exerciseA single resistance exercise session of the leg press and leg extension exercise | Behavioural | Placebo, Whey and collagen protein blend |
Primary outcome
Muscle protein synthesis rates exercised leg
Time frame: 0-5 hours
Muscle protein synthesis rates are calculated using L-ring-13C6-phenylalanine tracer and provided as 1 integrated value over the specified timeframe using plasma as precursor of the exercised leg.
Muscle protein synthesis rates rested leg
Time frame: 0-5 hours
Muscle protein synthesis rates are calculated using L-ring-13C6-phenylalanine tracer and provided as 1 integrated value over the specified timeframe using plasma as precursor of the rested leg.
4 secondary outcomes
Muscle protein synthesis rates
Time frame: -3-0 hours
Plasma glucose concentrations
Time frame: 0-5 hours
Plasma insulin concentrations
Time frame: 0-5 hours
Plasma amino acids concentrations
Time frame: 0-5 hours
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Jul 2023.
- Derived from this study: PubMed 39501478Aussieker T, Kaiser J, Hermans WJH, Hendriks FK, Holwerda AM, Senden JM, VAN Kranenburg JMX, Goessens JPB, Braun U, Baar K, Snijders T, VAN Loon LJC. Ingestion of a Whey Plus Collagen Protein Blend Increases Myofibrillar and Muscle Connective Protein Synthesis Rates. Med Sci Sports Exerc. 2025 Mar 1;57(3):544-554. doi: 10.1249/MSS.0000000000003596. Epub 2024 Nov 6.
- Individual participant dataSharing planned: Undecided
Related trials for Muscle Protein Synthesis
Recruiting
Effects of Lean Pork Loin Intake on Protein Homeostasis and Glucose Regulation in Prediabetic Adults
Hyperglycaemia (Non Diabetic), Prediabetes
Not yet recruiting
Acute Effects of Ketone Monoester Co-Ingestion With Dietary Protein on Whole-Body Phenylalanine Oxidation, Phenylalanine Retention, and Myofibrillar Protein Breakdown Following Resistance Exercise in Older Males
Ketosis, Resistance Exercise
Active, not recruitingObservational study
Translation and Validation of the Limbs, Pain, Autonomy, Depression, Anxiety and Quality of Life Scales in Albanian
Musculoskeletal Pain, Autonomy
Active, not recruitingPhase 2
GRK-Biased Activation Via β2-Adrenergic Receptors in Human Skeletal Muscle
Overweight and Obesity
Active, not recruiting
Nutrient Profile and Muscle Protein Synthesis in Response to Corn Bread Made From Refined Versus Whole Grain Maize Flour
Effect of Food
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Whey/collagen protein blend and Resistance exercise in people with Muscle Protein Synthesis, run by Maastricht University Medical Center at 1 site in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Muscle protein synthesis rates exercised leg (time frame: 0-5 hours). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05386771, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2023.